Introducción
Custom supplement formulation turns a product concept into a specification that can be sourced, tested, packaged, and manufactured consistently. An attractive ingredient idea is only a starting point. The brand and manufacturer must align dosage, dosage form, ingredient compatibility, sensory targets, testing, packaging, cost, and production feasibility before commercial scale-up.
This guide explains Jabelli’s workflow, typical timing references, and the decisions a brand should make before development. Each project requires its own technical review.
What Is Custom Supplement Formulation?
Custom supplement formulation is the structured development of a product around a defined brief. It connects the brand’s positioning and target market with a feasible formula, process, quality specification, test plan, and package. The result should provide a documented basis for commercial production.
Projects can begin in several ways:
- A stock or white-label formulauses an established starting specification with limited available changes.
- A modified or semi-custom formulaadapts an existing base, subject to feasibility review.
- A fully custom formulais developed around a new ingredient, dosage, sensory, or positioning brief.
- A customer-owned formula transferevaluates whether an existing formula can run on the manufacturer’s materials, equipment, process, testing, and packaging system.
These labels do not determine the scope. A vitamin formulation that changes flavor, dosage, or an active ingredient may require new sampling. A transferred formula may need adjustments for supply, processing, stability, or the destination market.
Jabelli’s Custom Supplement Formulation Process
Jabelli projects typically move through the stages below, although the sequence may be adjusted for the product, dosage form, ingredients, and target market.
1. Customer Requirement Assessment
The brand provides its target market, concept or formula, dosage form, dosage and serving size, flavor, packaging, budget, quantity, and target launch date. This allows the team to identify missing decisions and conflicts.
2. R&D and Ingredient Feasibility Review
Formulators, food engineers, quality personnel, and regulatory support personnel review the proposed formula. Ingredient evaluation may consider supplier information, specifications, stability, compatibility, availability, processing behavior, and target-market requirements.
The review also considers format-specific constraints. Capsules involve capacity, density, flow, and dose. Tablets add size, hardness, disintegration, and compressibility. Gummies require attention to active loading, taste, texture, heat sensitivity, and stability. Powders raise flavor, dispersibility, hygroscopicity, and blend-uniformity questions. Liquids and drops involve solubility, sedimentation, microbial control, and stability, while softgels require fill-material and shell-compatibility review.
Jabelli supports hard capsules, softgels, gummies, tablets, powders, drops, liquid supplements, and pet supplements, with other formats subject to assessment. Final feasibility depends on the formula, ingredient load, process, target market, package, and commercial specification. Brands evaluating format options can review Jabelli’s capsule manufacturing y gummy supplement manufacturing pages as starting references.

3. Quotation and Project Scope
After the initial review, the quotation should identify the formula route, sample work, testing, packaging, quantity assumptions, and commercial production requirements. Jabelli does not currently apply a separate standard R&D or formula-modification fee, but samples, special ingredients, third-party testing, special packaging, and other project requirements may create additional charges.
Sample development requires a US$20 upfront sample charge, with shipping charged separately. The sample charge may be credited toward a subsequent bulk order according to the confirmed terms. The commercial order must still meet the applicable MOQ for the dosage form; there is no single R&D MOQ that applies to every project.
4. Custom Sample Development
The formulation team prepares a supplement prototype against the agreed brief. A useful sample review covers more than appearance. The brand should evaluate the intended dose, flavor, sweetness, aroma, texture, color, ease of use, package concept, and alignment with the product positioning.
Projects are generally planned around one revision round. Changes to flavor, dosage, or ingredients require a new feasibility review and may involve an additional sample charge and a revised schedule.
5. Customer Review and Approval
The customer documents its feedback and approves the relevant sample and specification. Clear, consolidated comments are more useful than separate informal messages because the manufacturer must identify which version controls the next step. Approval should cover the attributes defined in the project, not taste alone.

6. Internal Testing
Depending on the product and agreed scope, internal testing may include ingredient or active content, microbiological testing, heavy metals, and selected compound-specific testing. If an independent laboratory is required, third-party testing is charged separately. The methods, acceptance criteria, samples, and reporting requirements should be agreed before commercial production.
7. Scale-Up and First-Batch Confirmation
Jabelli uses an internal small-scale trial, pilot-scale evaluation, and first-batch confirmation to compare the commercial process with the approved prototype. The team monitors relevant quality and processing attributes, adjusts controllable process parameters where necessary, and confirms the production specification before routine manufacturing. This approach manages scale-up differences; it does not claim that every variation can be eliminated.

8. Commercial Production
Commercial production begins after the formula, materials, package, testing scope, approvals, and order requirements are ready. Jabelli’s broader servicios de fabricación de suplementos include custom formulation and multiple dosage forms, but the final production plan remains specific to the approved project.
Typical Formulation and Production Timelines
The following are stage references under normal project conditions when information is complete, materials and packaging are available, and customer feedback is timely.
|
Stage |
Typical reference time |
What may affect it |
|
Initial feasibility assessment |
About 1 day |
Completeness of brief, ingredient complexity, target-market questions |
|
Ingredient procurement |
About 7 days |
Availability, supplier minimums, special ingredients, required documents |
|
Custom sample development |
About 7 days |
Dosage form, flavor work, ingredient behavior, revision requests |
|
Internal testing |
About 3 days |
Test scope, method, product characteristics, sample readiness |
|
Commercial production |
About 7 days |
Material and packaging readiness, approvals, scheduling, confirmed specifications |
These periods are not an unconditional guarantee or a fixed end-to-end lead time. Some activities may overlap, so they should not simply be added together. An unsatisfactory sample, ingredient shortage, special procurement, package production, added testing, or delayed feedback can change the schedule. The approximately seven-day production reference applies to the production stage once its conditions are ready; it does not cover the entire path from concept to shipment.
Key Formulation Decisions for Brand Owners
Early decisions help identify trade-offs before the brand commits to claims, artwork, or launch dates.
|
Decision |
Why it matters |
What the brand should provide |
|
Target market |
Influences ingredient review, labeling, claims, testing, and documents |
Countries, sales channels, intended positioning |
|
Formula route |
Defines whether the project uses a stock, modified, custom, or transferred formula |
Existing specification, reference product, or development objective |
|
Dosage and format |
Affects ingredient capacity, process, sensory profile, package, and MOQ |
Amount per serving, serving size, preferred dosage form |
|
Sensory target |
Guides flavor, sweetness, texture, color, and user experience |
Reference profile and unacceptable attributes |
|
Testing and documents |
Establishes acceptance and release requirements |
Required tests, COA, specifications, reports, and market-specific needs |
|
Package |
Protects the product and affects filling, stability, transport, and presentation |
Preferred container, closure, count, barrier needs, and artwork status |
|
Commercial limits |
Keeps technical choices aligned with the business case |
Target budget, estimated quantity, launch date, and reorder expectations |
|
Confidentiality and ownership |
Clarifies access, use, and deliverables |
NDA needs and proposed contractual ownership terms |
The target market should be identified at the beginning. For U.S. projects, the FDA explains that supplement firms are responsible for evaluating safety and labeling before marketing, while the FTC expects health-related advertising claims to be truthful, not misleading, and adequately substantiated. Other markets have their own requirements, so an assessment for one destination should not be treated as universal approval.
Packaging belongs in this decision process rather than at the end. Moisture protection, light protection, sealing, transportation conditions, and dosage-form characteristics can affect product stability and commercial presentation. A package that suits a capsule may not suit a hygroscopic powder, light-sensitive liquid, or heat-sensitive gummy.
From Prototype to Commercial Production
A supplement prototype demonstrates an agreed direction, but commercial equipment, batch size, material handling, and filling conditions can change product behavior. During formulation scale-up, the manufacturer compares the approved prototype with small-scale, pilot, and first-batch results.
Monitored attributes depend on the format—for example, powder flow and uniformity, gummy texture and stability, tablet compressibility and disintegration, or liquid solubility and microbial control.
If a brand changes flavor, dosage, or ingredients after the sample stage, the revised brief can affect feasibility, procurement, testing, packaging, cost, and timing. The change should therefore be recorded as a new controlled version rather than applied informally during production.
Testing and Documentation
Testing confirms agreed attributes. Jabelli’s internal scope may include active or ingredient content, microbiological testing, heavy metals, and selected compound-specific tests. Separate third-party work should define the methods, criteria, report, and timing.
Depending on the agreed scope, final project documents may include a Certificate of Analysis, product specification, test reports, allergen statement, and stability-related documentation. Not every order automatically includes every test or document. The required package should reflect the product, target market, buyer responsibilities, and commercial agreement.

Confidentiality and Formula Ownership
Jabelli can enter into an NDA, and a customer-supplied formula can be protected through contractual confidentiality terms. Ownership of a newly developed formula is defined in the project agreement and should be confirmed before development begins. There is no single public ownership promise that applies to every project.
The agreement should identify protected information, permitted use, access, ownership or licensing, and the records to be delivered. This is commercial planning, not legal advice; each party should obtain appropriate advice.
Common Causes of Delays
Formulation schedules can change when:
- a sample does not meet the agreed sensory or technical target;
- an ingredient is unavailable or requires special procurement;
- packaging production or artwork approval is incomplete;
- flavor, dosage, or ingredient requirements change;
- additional testing or documentation is introduced;
- customer feedback or approval takes longer than planned; or
- the project brief is incomplete or contains conflicting requirements.
A milestone-based schedule with named inputs and decision owners is more reliable than one date detached from the project scope.
Information to Send for a Feasibility Review
Provide the following where available:
- target market and sales channel;
- product concept, positioning, and intended consumer group;
- proposed ingredient list, reference product, or existing formula;
- preferred dosage form, dosage, and serving size;
- flavor, color, texture, and appearance requirements;
- ingredients or allergens to avoid;
- packaging preference;
- target budget and estimated order quantity;
- target launch date; and
- required testing, certifications, documents, or exclusions.
The brief need not answer every technical question; it should reveal feasibility gaps and support the next controlled step.
Start a Custom Supplement Formulation Review
Successful custom supplement formulation depends on clear requirements, early feasibility review, practical technical and commercial trade-offs, and timely approvals between the brand and manufacturer. A well-defined brief helps the team evaluate ingredients, dosage form, sensory targets, testing, packaging, ownership, scale-up, and production as one connected project.
Send Jabelli your product concept or existing formula for an initial feasibility review through the contact page. Include the target market, dosage form, intended dose, estimated quantity, package preference, and launch objective so the team can respond with a project-specific next step.
References and Regulatory Resources
- FDA — Dietary Supplements“S. supplement regulatory responsibilities, including safety and labeling before marketing.” https://www.fda.gov/food/dietary-supplements
- FTC — Health Products Compliance Guidance“Truthfulness, non-deception, and substantiation principles for health-related advertising.” https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
Preguntas frecuentes
How long does custom supplement formulation take?
Timelines vary by project. Typical references are about one day for initial feasibility assessment, seven days for sample development, seven days for ingredient procurement, three days for internal testing, and seven days for commercial production. These stages may overlap and do not represent a guaranteed total lead time.
How many sample revision rounds are usually included?
Projects are generally planned around one revision round. Changes to flavor, dosage, or ingredients require a new feasibility review and may involve an additional sample charge and revised development timeline.
Can Jabelli sign an NDA?
Yes. Jabelli can sign an NDA, and customer-supplied formulas can be protected through contractual confidentiality terms.
Who owns a newly developed supplement formula?
Ownership is determined by the project agreement between Jabelli and the customer. The ownership terms should be confirmed before formulation work begins.
Can I transfer an existing formula to Jabelli?
Yes, subject to a feasibility review. Jabelli will evaluate the formula, ingredient specifications, dosage form, manufacturing requirements, testing needs, packaging, and target market before confirming the transfer.
What information is needed for an initial feasibility review?
Please provide your target market, ingredient list or existing formula, preferred dosage form, dosage and serving size, flavor requirements, packaging preference, target budget, estimated order quantity, and target launch date.